Needle-Free Diabetes Care Market Analysis Global Industry, Size, Emerging Factors, Competitive Landscape, Regional Analysis and Forecast to 2023

Market Research Future (MRFR) has launched a new release on the Needle-Free Diabetes Care Market Research Report- Forecast To 2023. The report delivers a thorough understanding of the market’s present status and likely future growth trajectory over the forecast period

Needle-Free Diabetes Care Market Highlights

According to International Diabetes Federation, diabetes is becoming one of the major diseases because about 420 million adults of the total global population had diabetes in 2016. On account of lack of effective treatment for this disorder, many manufacturers are continuously trying to develop new drugs and more convenient drug delivery devices

Global Needle-Free Diabetic Care Market Is Expected to grow at a CAGR of 7.5% during the forecast period 2017-2023.

Leading Market Players

Some of the major players in the global needle-free diabetic care market: Antares Pharma, Inc. (US), Bioject Medical Technologies Inc. (US), Endo International plc (US), European Pharma Group (Netherland), PharmaJet (US), Medical International Technology, Inc. (US), Valeritas, Inc. (US), PenJet Corporation (US), INJEX Pharma AG (Germany), National Medical Products Inc. (US), Crossject SA (France), Zogenix, Inc. (US), 3M Company (US).

Market Segmentation:

The global needle-free diabetic care market is segmented on the basis of devices types into treatment devices and diagnostic devices. Treatment devices are further segmented into insulin jet injector, insulin pen, insulin inhaler, and insulin patch & pump. Diagnostic devices are also further segmented into continuous glucose monitoring and instant glucose monitoring. On the basis of treatment type, the market is segmented into oral insulin, inhaled insulin, insulin patch and others. On the basis of applications, the market is segmented into insulin delivery and others. On the basis of end users, the market is segmented into diagnostic centers, hospitals & clinics, and other.

Needle-Free Diabetes Care Market Research Report, By Devices Types (Treatment Devices And Diagnostic Devices), By Treatment (Oral Insulin, Inhaled Insulin, Insulin Patch, Others), By Application (Insulin Delivery And Other), By End Users (Diagnostic Centers, Hospitals & Clinics And Other)-Forecast Till 2023 @https://www.marketresearchfuture.com/reports/needle-free-diabetes-care-market-912

Regional Analysis:

The global needle-free diabetic care market is segmented: America, Europe, Asia Pacific and the Middle East and Africa. America accounts for the largest needle-free diabetic care market. According to American Diabetic Association, 29 million Americans were suffering from diabetes in 2016, which is 9.3% of total American population. Obese patients are more prone to diabetes; increasing number of obese population in America is the major driving factor in the growth of the market. Europe is the second largest market, which is followed by Asia Pacific. Increasing awareness among the people and government support for the research and development have encouraged the growth of the market in Europe. Asia Pacific is the fastest growing needle-free diabetic care market globally. China and India contribute a major share in the Asia Pacific needle-free diabetes care market due to the presence of huge diabetic population. The Middle East & Africa holds the lowest share in the global needle-free diabetic care market.

Latest Trending Reports

Syringe and Needle Market Research Report - Global Forecast to 2027

Global Pacemaker Market Research Report- Forecast To 2022

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

https://www.marketresearchfuture.com/